{
    "nctId": "NCT00749931",
    "briefTitle": "MarginProbe, a Device for Intraoperative Assessment of Margin Status in Breast Conservation Surgery",
    "officialTitle": "MarginProbe, a Device for Intraoperative Assessment of Margin Status in Breast Conservation Surgery",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "SUPPORTIVE_CARE",
    "enrollmentCount": 664,
    "primaryOutcomeMeasure": "The Primary Effectiveness Endpoint is a Measure of Intraoperative Success in Addressing Positive Margins as Detected by Permanent Pathology)by Additional Oriented Tissue Re-excision From the Surgical Cavity.",
    "eligibilityCriteria": "Inclusion Criteria:\n\n1. Women histologically diagnosed with carcinoma of the breast\n2. Women with non-palpable malignant lesions, requiring image guided localization.\n3. Undergoing lumpectomy (partial mastectomy) procedure.\n4. Age 18 years or more\n5. Signed ICF\n\nExclusion Criteria:\n\n1. Multicentric disease (histologically diagnosed cancer in two different quadrants of the breast)\n2. Bilateral disease (diagnosed cancer in both breasts)\n3. Neoadjuvant systemic therapy\n4. Previous radiation in the operated breast\n5. Prior surgical procedure in the same breast\n6. Implants in the operated breast\n7. Pregnancy\n8. Lactation\n9. Participating in any other investigational study for either drug or device which can influence collection of valid data under this study.",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}